# pathway_0126

[All questions and paired results](../README.md) · [Method](../METHOD.md) · [Source credits](../THIRD_PARTY_NOTICES.md)

**Task:** `pathway`  
**Author expected answer:** **A** — Carbohydrate degradation

| Reviewer | Expected-answer support | Reasoning / lookup | Validity |
|---|---|---|---|
| GPT-6 Luna | supported | lookup-dependent | valid_review |
| Qwen3.8-Flash-Next-NVFP4 | supported | reasoning-supported | valid_review |

**Paired comparison:** key agree; reasoning differ. Agreement is not proof of correctness. These are separate AI judgments, with no forced consensus or changed key.

## Complete original question

```text
[Protein Sequence]
MAAVTRYSGKVVVVTGGSRGIGAAIVRAFVDSGAQVVFCDKDEAGGRALEQELSGTVFIPGDVTQERDLQTLVSETLSRFGHLDCVVNNAGYHPPAQLPEETSAQGFRQLLEVNLLGTYTLIKLALPHLRKSRGNIINISSLVGAIGQSQALTYVATKGAVTAMTKALALDESRHGVRVNCISPGNIWTPLWEELAASTSDPRATILEGTLAQPLGRMGQPAEVAAAAVFLASEATFCTGLELLVTGGAELGYGRKASKSSLGEVPTLPPNVH

[Multiple Choices]
A. Carbohydrate degradation
B. Alkaloid biosynthesis. .
C. peptidoglycan degradation. .
D. pyruvate from D-glyceraldehyde 3-phosphate: step 2/5. .
```

<details>
<summary>Original system instructions, verbatim</summary>

```text
You are an excellent scientist. Analyze the provided protein-related task carefully and choose the correct answer from the multiple-choice options.

The current task is about Protein Pathway Prediction, which is to predict the primary metabolic or signaling pathway in which a given protein functions. Biological pathways are series of chemical reactions occurring within a cell that are essential for life. Based on the protein's amino acid sequence, you should identify the most relevant pathway from the given options.. The inputs provided by the user for this task include:

* Protein Sequence: The amino acid sequence of the protein.
* Multiple Choices: Candidate answers for the protein-related question.

Please think step-by-step about this problem:
1. Analyze the protein sequence carefully.
2. Consider the biological context and function.
3. Evaluate each multiple-choice option.
4. Provide your reasoning process.
5. Finally, give your answer.

Provide your response in the following format:
1. reasoning: [Your detailed reasoning here]
2. answer: Your final answer, which should be "A", "B", "C" or "D".
```

</details>

## GPT-6 Luna

**Saved status:** `valid_review`.

### Expected-answer support: supported

> The sequence matches the mouse UniProt entry annotated as L-fucose dehydrogenase, with the pathway listed as carbohydrate degradation (including L-fucose degradation). This supports choice A as a database annotation, though the pathway annotation is transferred by similarity rather than direct experimental evidence in the supplied record.

Citations as saved: [C1](#evidence-c1), [C4](#evidence-c4), [C5](#evidence-c5), [H2](#evidence-h2).

### Reasoning versus lookup: lookup-dependent

**Discriminating biological argument**

> Sequence motifs may suggest an NAD-dependent dehydrogenase, but that does not identify its substrate or distinguish general carbohydrate degradation from the more specific glycolytic option.


**Missing item-specific fact**

> The protein's substrate specificity as L-fucose dehydrogenase and its associated pathway annotation are not given in the question.


**Reason**

> Choosing A over the other options requires protein-specific functional knowledge or annotation; the sequence alone does not establish that this dehydrogenase acts on L-fucose.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The matched database annotation supports A. Although D is also carbohydrate-related, it specifies a distinct glycolytic step, and the available evidence does not support assigning this protein to that step.


### Important caveats

- The reviewer-only database record matches the supplied sequence, but the author’s exact source snapshot is unknown.
- The pathway annotation is supported by transferred evidence (ECO:0000250), not by direct experimental evidence shown here.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "Sequence motifs may suggest an NAD-dependent dehydrogenase, but that does not identify its substrate or distinguish general carbohydrate degradation from the more specific glycolytic option.",
    "judgment": "lookup_or_memorization_dependent",
    "missing_item_specific_fact": "The protein's substrate specificity as L-fucose dehydrogenase and its associated pathway annotation are not given in the question.",
    "reason": "Choosing A over the other options requires protein-specific functional knowledge or annotation; the sequence alone does not establish that this dehydrogenase acts on L-fucose."
  },
  "case_id": "pathway_0126",
  "expected_answer_check": {
    "evidence_ids": [
      "C1",
      "C4",
      "C5",
      "H2"
    ],
    "judgment": "supported",
    "reason": "The sequence matches the mouse UniProt entry annotated as L-fucose dehydrogenase, with the pathway listed as carbohydrate degradation (including L-fucose degradation). This supports choice A as a database annotation, though the pathway annotation is transferred by similarity rather than direct experimental evidence in the supplied record."
  },
  "important_caveats": [
    "The reviewer-only database record matches the supplied sequence, but the author’s exact source snapshot is unknown.",
    "The pathway annotation is supported by transferred evidence (ECO:0000250), not by direct experimental evidence shown here."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched database annotation supports A. Although D is also carbohydrate-related, it specifies a distinct glycolytic step, and the available evidence does not support assigning this protein to that step."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text
{
  "case_id": "pathway_0126",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "The sequence matches the mouse UniProt entry annotated as L-fucose dehydrogenase, with the pathway listed as carbohydrate degradation (including L-fucose degradation). This supports choice A as a database annotation, though the pathway annotation is transferred by similarity rather than direct experimental evidence in the supplied record.",
    "evidence_ids": ["C1", "C4", "C5", "H2"]
  },
  "answerability_check": {
    "judgment": "lookup_or_memorization_dependent",
    "discriminating_biological_argument": "Sequence motifs may suggest an NAD-dependent dehydrogenase, but that does not identify its substrate or distinguish general carbohydrate degradation from the more specific glycolytic option.",
    "missing_item_specific_fact": "The protein's substrate specificity as L-fucose dehydrogenase and its associated pathway annotation are not given in the question.",
    "reason": "Choosing A over the other options requires protein-specific functional knowledge or annotation; the sequence alone does not establish that this dehydrogenase acts on L-fucose."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The matched database annotation supports A. Although D is also carbohydrate-related, it specifies a distinct glycolytic step, and the available evidence does not support assigning this protein to that step."
  },
  "important_caveats": [
    "The reviewer-only database record matches the supplied sequence, but the author’s exact source snapshot is unknown.",
    "The pathway annotation is supported by transferred evidence (ECO:0000250), not by direct experimental evidence shown here."
  ]
}
```

</details>

## Qwen3.8-Flash-Next-NVFP4

**Saved status:** `valid_review`.

### Expected-answer support: supported

> UniProt entry E9Q3D4 (sequence matched, 273 aa) annotates the protein as L-fucose dehydrogenase (EC 1.1.1.122) with the pathway comment 'Carbohydrate degradation; L-fucose degradation' (evidence ECO:0000250, inferred by similarity from Q9MYP6). The expected answer 'Carbohydrate degradation' matches the top-level UniProt pathway category. The annotation is computational (similarity-based) rather than experimentally validated for this specific protein, but it is the current curated assignment and is consistent with the protein's function as a sugar-oxidizing dehydrogenase.

Citations as saved: [C4](#evidence-c4), [C5](#evidence-c5), [H1](#evidence-h1), [H2](#evidence-h2).

### Reasoning versus lookup: reasoning-supported

**Discriminating biological argument**

> The sequence contains a canonical Rossmann-fold motif (VVTGGSRGIGAAIV, residues ~7–20) and an SDR-family catalytic tetrad signature (TGxxxYG), identifying it as a short-chain dehydrogenase/reductase. Among the four options: (C) peptidoglycan degradation is implausible for a mammalian (mouse) protein since peptidoglycan is a bacterial cell-wall polymer; (B) alkaloid biosynthesis is atypical for a mammalian SDR; (D) 'pyruvate from D-glyceraldehyde 3-phosphate: step 2/5' describes a specific glycolytic step catalyzed by enzymes (e.g., enolase, pyruvate kinase) with folds and active-site architectures distinct from the SDR family. Eliminating B, C, and D leaves A (Carbohydrate degradation) as the only viable pathway for a mammalian sugar-oxidizing dehydrogenase.


**Missing item-specific fact**

> The precise substrate identity (L-fucose vs. steroid or other alcohol) is not deducible from sequence alone; the alternative UniProt name 'Hydroxysteroid 17-beta dehydrogenase 14' could mislead toward steroid metabolism. Positive confirmation that this SDR acts on a sugar (rather than a steroid) relies on the similarity-based annotation or prior knowledge of this specific protein.


**Reason**

> Although the exact substrate (L-fucose) requires item-specific knowledge, the four provided options are sufficiently disparate that general biological reasoning—recognizing the SDR fold, eliminating bacterial peptidoglycan from a mouse protein, ruling out alkaloid biosynthesis, and distinguishing SDR architecture from glycolytic enzymes—meaningfully narrows the answer to A without memorizing the UniProt entry.


### Question ambiguity

**Multiple defensible options, exactly as saved:**

```json
[]
```

> The four choices span clearly distinct biochemical categories (general carbohydrate catabolism, alkaloid biosynthesis, bacterial cell-wall degradation, a specific glycolytic step). No two options are near-synonymous or equally defensible given the sequence and organism context.


### Important caveats

- The pathway annotation carries evidence code ECO:0000250 (inferred by similarity from Q9MYP6), not direct experimental validation for E9Q3D4.
- The alternative protein name 'Hydroxysteroid 17-beta dehydrogenase 14' could mislead a model toward steroid/lipid pathways, which are not offered as options but highlight that positive substrate assignment is non-trivial from sequence alone.
- The UniProt entry was first public in April 2025; the author's source snapshot date is unknown, though the historical archived record (entry version 95) confirms the same pathway annotation.

<details>
<summary>Complete saved parsed visible review</summary>

```json
{
  "answerability_check": {
    "discriminating_biological_argument": "The sequence contains a canonical Rossmann-fold motif (VVTGGSRGIGAAIV, residues ~7–20) and an SDR-family catalytic tetrad signature (TGxxxYG), identifying it as a short-chain dehydrogenase/reductase. Among the four options: (C) peptidoglycan degradation is implausible for a mammalian (mouse) protein since peptidoglycan is a bacterial cell-wall polymer; (B) alkaloid biosynthesis is atypical for a mammalian SDR; (D) 'pyruvate from D-glyceraldehyde 3-phosphate: step 2/5' describes a specific glycolytic step catalyzed by enzymes (e.g., enolase, pyruvate kinase) with folds and active-site architectures distinct from the SDR family. Eliminating B, C, and D leaves A (Carbohydrate degradation) as the only viable pathway for a mammalian sugar-oxidizing dehydrogenase.",
    "judgment": "reasoning_supported",
    "missing_item_specific_fact": "The precise substrate identity (L-fucose vs. steroid or other alcohol) is not deducible from sequence alone; the alternative UniProt name 'Hydroxysteroid 17-beta dehydrogenase 14' could mislead toward steroid metabolism. Positive confirmation that this SDR acts on a sugar (rather than a steroid) relies on the similarity-based annotation or prior knowledge of this specific protein.",
    "reason": "Although the exact substrate (L-fucose) requires item-specific knowledge, the four provided options are sufficiently disparate that general biological reasoning—recognizing the SDR fold, eliminating bacterial peptidoglycan from a mouse protein, ruling out alkaloid biosynthesis, and distinguishing SDR architecture from glycolytic enzymes—meaningfully narrows the answer to A without memorizing the UniProt entry."
  },
  "case_id": "pathway_0126",
  "expected_answer_check": {
    "evidence_ids": [
      "C4",
      "C5",
      "H1",
      "H2"
    ],
    "judgment": "supported",
    "reason": "UniProt entry E9Q3D4 (sequence matched, 273 aa) annotates the protein as L-fucose dehydrogenase (EC 1.1.1.122) with the pathway comment 'Carbohydrate degradation; L-fucose degradation' (evidence ECO:0000250, inferred by similarity from Q9MYP6). The expected answer 'Carbohydrate degradation' matches the top-level UniProt pathway category. The annotation is computational (similarity-based) rather than experimentally validated for this specific protein, but it is the current curated assignment and is consistent with the protein's function as a sugar-oxidizing dehydrogenase."
  },
  "important_caveats": [
    "The pathway annotation carries evidence code ECO:0000250 (inferred by similarity from Q9MYP6), not direct experimental validation for E9Q3D4.",
    "The alternative protein name 'Hydroxysteroid 17-beta dehydrogenase 14' could mislead a model toward steroid/lipid pathways, which are not offered as options but highlight that positive substrate assignment is non-trivial from sequence alone.",
    "The UniProt entry was first public in April 2025; the author's source snapshot date is unknown, though the historical archived record (entry version 95) confirms the same pathway annotation."
  ],
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four choices span clearly distinct biochemical categories (general carbohydrate catabolism, alkaloid biosynthesis, bacterial cell-wall degradation, a specific glycolytic step). No two options are near-synonymous or equally defensible given the sequence and organism context."
  }
}
```

</details>

<details>
<summary>Exact saved visible final text</summary>

```text


{
  "case_id": "pathway_0126",
  "expected_answer_check": {
    "judgment": "supported",
    "reason": "UniProt entry E9Q3D4 (sequence matched, 273 aa) annotates the protein as L-fucose dehydrogenase (EC 1.1.1.122) with the pathway comment 'Carbohydrate degradation; L-fucose degradation' (evidence ECO:0000250, inferred by similarity from Q9MYP6). The expected answer 'Carbohydrate degradation' matches the top-level UniProt pathway category. The annotation is computational (similarity-based) rather than experimentally validated for this specific protein, but it is the current curated assignment and is consistent with the protein's function as a sugar-oxidizing dehydrogenase.",
    "evidence_ids": ["C4", "C5", "H1", "H2"]
  },
  "answerability_check": {
    "judgment": "reasoning_supported",
    "discriminating_biological_argument": "The sequence contains a canonical Rossmann-fold motif (VVTGGSRGIGAAIV, residues ~7–20) and an SDR-family catalytic tetrad signature (TGxxxYG), identifying it as a short-chain dehydrogenase/reductase. Among the four options: (C) peptidoglycan degradation is implausible for a mammalian (mouse) protein since peptidoglycan is a bacterial cell-wall polymer; (B) alkaloid biosynthesis is atypical for a mammalian SDR; (D) 'pyruvate from D-glyceraldehyde 3-phosphate: step 2/5' describes a specific glycolytic step catalyzed by enzymes (e.g., enolase, pyruvate kinase) with folds and active-site architectures distinct from the SDR family. Eliminating B, C, and D leaves A (Carbohydrate degradation) as the only viable pathway for a mammalian sugar-oxidizing dehydrogenase.",
    "missing_item_specific_fact": "The precise substrate identity (L-fucose vs. steroid or other alcohol) is not deducible from sequence alone; the alternative UniProt name 'Hydroxysteroid 17-beta dehydrogenase 14' could mislead toward steroid metabolism. Positive confirmation that this SDR acts on a sugar (rather than a steroid) relies on the similarity-based annotation or prior knowledge of this specific protein.",
    "reason": "Although the exact substrate (L-fucose) requires item-specific knowledge, the four provided options are sufficiently disparate that general biological reasoning—recognizing the SDR fold, eliminating bacterial peptidoglycan from a mouse protein, ruling out alkaloid biosynthesis, and distinguishing SDR architecture from glycolytic enzymes—meaningfully narrows the answer to A without memorizing the UniProt entry."
  },
  "question_ambiguity": {
    "multiple_defensible_options": [],
    "reason": "The four choices span clearly distinct biochemical categories (general carbohydrate catabolism, alkaloid biosynthesis, bacterial cell-wall degradation, a specific glycolytic step). No two options are near-synonymous or equally defensible given the sequence and organism context."
  },
  "important_caveats": [
    "The pathway annotation carries evidence code ECO:0000250 (inferred by similarity from Q9MYP6), not direct experimental validation for E9Q3D4.",
    "The alternative protein name 'Hydroxysteroid 17-beta dehydrogenase 14' could mislead a model toward steroid/lipid pathways, which are not offered as options but highlight that positive substrate assignment is non-trivial from sequence alone.",
    "The UniProt entry was first public in April 2025; the author's source snapshot date is unknown, though the historical archived record (entry version 95) confirms the same pathway annotation."
  ]
}
```

</details>

## Existing project source checks of Luna’s review

The notes below were prepared for specific claims in the Luna review. They are not independent validation of Qwen’s claims, expert adjudication, or replacement verdicts.

## Project source-check notes

These project-authored, AI-assisted checks assess specific source claims. They are not expert adjudication and do not replace Luna’s saved review or the author key.

No additional case-specific project note was recorded. Citation membership checks do not establish that every scientific argument is correct.

## Reviewer-only source evidence

**Both reviewers received this source evidence separately from the original question. It was not available to the original evaluated model.** Source support and reasoning from the original sequence/choices are distinct assessments.

**Accession:** `E9Q3D4` (recovered from dataset image-path metadata, not original question text).  
**Sequence applicability:** historical matched; current matched.  
**Historical cutoff:** 2026-05-07; archived entry version 95. Exact author snapshot unknown.

- All evidence and source identity in this section are reviewer-only and were absent from the evaluated model input.
- UniProt annotations may be experimental, computational, or transferred by similarity; evidence codes and qualifiers are retained.
- The 2026-05-07 cutoff approximates the pinned repository date; the author data-construction date and exact source snapshot remain unknown.
- Selected source fields are excerpts; missing annotation is not evidence of falsehood. Primary papers were not comprehensively retrieved or independently validated.

### Evidence C1

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E9Q3D4.json)  
**Locator:** `/primaryAccession`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:08.225634+00:00.  

```json
"E9Q3D4"
```

Source SHA-256: `bd47482a576a5aceb231929788ca2f5078c56926357a52cc62412f8c497bcd3f`.

### Evidence C4

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E9Q3D4.json)  
**Locator:** `/proteinDescription`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:08.225634+00:00.  

```json
{"alternativeNames":[{"fullName":{"value":"Hydroxysteroid 17-beta dehydrogenase 14"}}],"recommendedName":{"ecNumbers":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"Q9BPX1","source":"UniProtKB"}],"value":"1.1.1.122"}],"fullName":{"value":"L-fucose dehydrogenase"}}}
```

Source SHA-256: `bd47482a576a5aceb231929788ca2f5078c56926357a52cc62412f8c497bcd3f`.

### Evidence C5

[UniProtKB current entry](https://rest.uniprot.org/uniprotkb/E9Q3D4.json)  
**Locator:** `/comments/4`  
**Scope:** current snapshot; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Retrieved:** 2026-11-02T04:28:08.225634+00:00.  

```json
{"commentType":"PATHWAY","texts":[{"evidences":[{"evidenceCode":"ECO:0000250","id":"Q9MYP6","source":"UniProtKB"}],"value":"Carbohydrate degradation; L-fucose degradation"}]}
```

Source SHA-256: `bd47482a576a5aceb231929788ca2f5078c56926357a52cc62412f8c497bcd3f`.

### Evidence H1

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E9Q3D4?format=txt&versions=95)  
**Locator:** `lines 1-14`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 95 / 1.  
**Retrieved:** 2026-11-02T04:28:17.926007+00:00.  

```text
ID   DHB14_MOUSE             Reviewed;         273 AA.
AC   E9Q3D4;
DT   09-APR-2025, integrated into UniProtKB/Swiss-Prot.
DT   05-APR-2011, sequence version 1.
DT   28-JAN-2026, entry version 95.
DE   RecName: Full=L-fucose dehydrogenase;
DE            EC=1.1.1.122 {ECO:0000250|UniProtKB:Q9BPX1};
DE   AltName: Full=Hydroxysteroid 17-beta dehydrogenase 14;
GN   Name=Hsd17b14 {ECO:0000312|MGI:MGI:1913315}; Synonyms=Dhrs10, retSDR3;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
```

Source SHA-256: `e2e2499fa9a4008684b0b5a4af04f9fe0ed35d0a8b57fcdbdd5131ae007b3673`.

### Evidence H2

[UniSave archived UniProt entry](https://rest.uniprot.org/unisave/E9Q3D4?format=txt&versions=95)  
**Locator:** `lines 51-52`  
**Scope:** record released no later than 2026-05-07; actual author source snapshot unknown.  
**Sequence comparison:** matched.  
**Entry / sequence version:** 95 / 1.  
**Retrieved:** 2026-11-02T04:28:17.926007+00:00.  

```text
CC   -!- PATHWAY: Carbohydrate degradation; L-fucose degradation.
CC       {ECO:0000250|UniProtKB:Q9MYP6}.
```

Source SHA-256: `e2e2499fa9a4008684b0b5a4af04f9fe0ed35d0a8b57fcdbdd5131ae007b3673`.

---

Original question/key: [pinned source](https://github.com/Rongdingyi/LiveProteinBench/blob/8b9710932511f816651fc1a7e8a1bc85c3c77767/dataset/QA/pathway.json), zero-based source row 126. © 2026 LiveProteinBench contributors; [CC BY 4.0](https://huggingface.co/datasets/LiveProteinBench/LiveProteinBench/blob/8428f64e33d53330f7745376d9c45de2d2c37eaf/LICENSE). UniProt and Gene Ontology credits are retained in [source notices](../THIRD_PARTY_NOTICES.md).
